In melanoma and lung cancer, TIM-3 expression on NK cells increases with disease stage [163,164,167], and higher percentages of TIM-3+ NK cells have been associated with lower survival of lung adenocarcinoma patients [163]. This evidence concerns the gene HAVCR2 and lung adenocarcinoma.